Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03230370
Other study ID # N201705071
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date December 1, 2018
Est. completion date May 20, 2020

Study information

Verified date September 2019
Source Taipei Medical University WanFang Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study purpose This study will explore whether an additional rehabilitation program that focus on either upper or lower extremity training facilitate the recovery in upper or lower extremity.

The recovery in both neurological status and motor functions will be explored.


Description:

Design A single-blinded (assessor-blinded) randomized controlled trial. Interventions The participants will be randomly assigned into two experiment groups (enhanced upper extremity program; and enhanced lower-extremity program).

Both groups receive routine rehabilitation including daily 50 mins of physical therapy and 50 mins of occupational therapy.

The enhanced upper extremity program group receives additional daily 50 mins program focusing on training of the hemiplegic upper extremity, while the enhanced lower-extremity program group receives additional daily 50 mins program focusing on training of the hemiplegic lower extremity. The participants receive 20-day training over a 4-week period. The additional program is designed to be specific to either upper-extremity or lower-extremity. Accordingly, one group can be used as the control group of the other one.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 20, 2020
Est. primary completion date May 20, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

1. First-ever stroke with the onset 10-90 days prior to the enrollment

2. Age: 20-80y

3. With a hemiplegic upper extremity with Brunnstrom stage in I~IV

4. Able to understand simple orders (1-step orders, such as "raise your hand, touch your head….)

5. Totally independent in activity of daily life before the onset of stroke

Exclusion Criteria:

1. Incompliance to the assessments or interventions due to unstable medical condition, abnormal cognition, or other conditions.

2. Stroke of brainstem or cerebellum

3. Had received craniotomy or ventriculoperitoneal shunting

4. Needs of orthoses in walking before the onset of stroke

5. Had had motor dysfunctions (eg, amputation, cerebral palsy, poliomyelitis or other neuromuscular diseases) before the stroke.

6. Intracranial hemorrhage caused by artereovenous malformation, aneurysm, or tumor

7. Able to walk independently for more than 50 meters.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
UFT
The EUEP group receives additional daily 50 mins program focusing on training of the hemiplegic upper extremity,
LFT
The ELEP group receives additional daily 50 mins program focusing on training of the hemiplegic lower extremity.

Locations

Country Name City State
Taiwan WanFang Hospital New Taipei City

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University WanFang Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fugl-Meyer Assessment (upper extremity subscale) The primary outcome is the change from baseline upper extremity subscale of Fugl-Meyer assessment at the end to 4-wk (post-intervention). 0-, 4- week
Secondary Action Research Arm Test (ARAT) A test that measures the upper extremity motor functions after the stroke. 0-, 4-, 8-, 12-, 24 week
Secondary Berg Balance Test A test that measures the balance functions. 0-, 4-, 8-, 12-, 24 week
Secondary Fugl-Meyer Assessment (lower extremity subscale) The FMA-LE (0-34) measures the lower extremity motor functions after the stroke. 0-, 4-, 8-, 12-, 24 week
Secondary Fugl-Meyer Assessment (upper extremity subscale) FMA-UE (0-66), the subscale of FMA that measures the poststroke neuro-motor functions. 0-, 4-, 8-, 12-, 24 week
Secondary Time required for 10 meter walking measuring the walking speed over a 10-meter distance 0-, 4-, 8-, 12-, 24 week
Secondary Stroke Impact Scale A measure for stroke-specific quality of life 0-, 4-, 8-, 12-, 24 week
Secondary Barthel Index to measure the activity of daily living 0-, 4-, 8-, 12-, 24 week
See also
  Status Clinical Trial Phase
Recruiting NCT04607174 - Voluntary Activation During Isokinetic Contractions in Subjects With Neuromotor Disorders N/A
Recruiting NCT05778474 - Mechanical Determinants of Upper Limbs Oscillation During Gait
Completed NCT01138995 - Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop Phase 4
Completed NCT02404857 - BCI Post-stroke Neurorehabilitation N/A
Recruiting NCT04635436 - Efficacy of Split Gait in the Treatment of Dynamic Asymmetries in Subjects With Pathologic Claudication